Home › Cancro metastatico › Michigan › Grand Rapids
Studi clinici su Cancro metastatico a Grand Rapids, MI
22 studi su Cancro metastatico cercano partecipanti presso sedi a Grand Rapids e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
In reclutamentoFase 2
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- South Texas Accelerated Research Therapeutics (START), Grand Rapids
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
In reclutamentoFase 1
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
In reclutamentoFase 1/2
- START Midwest, Grand Rapids
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
In reclutamentoFase 1
- ALX Center 3, Grand Rapids
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
In reclutamentoFase 2/3
- The Cancer and Hematology Centers, Grand Rapids
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 3
- The Cancer & Hematology Centers, Grand Rapids
- The Cancer & Hematology Centers, Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
In reclutamentoFase 1
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
In reclutamentoFase 1/2
- START Midwest, Grand Rapids
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
In reclutamentoFase 1/2
- START Midwest, Grand Rapids
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Clinical Study Site, Grand Rapids
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
In reclutamentoFase 3
- The Cancer & Hematology Centers, Grand Rapids
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
In reclutamentoFase 1/2
- South Texas Accelerated Research Therapeutics (START) - Midwest, Grand Rapids
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
In reclutamentoFase 1
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- START Midwest, Grand Rapids
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
In reclutamentoFase 1
- START Midwest, Grand Rapids
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
In reclutamentoFase 1/2
- Crinetics Study Site, Grand Rapids
CT-95 in Advanced Cancers Associated With Mesothelin Expression
In reclutamentoFase 1
- Context Investigational Site, Grand Rapids
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
In reclutamentoFase 1
- START Midwest, Grand Rapids
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
In reclutamentoFase 1/2
- Start Midwest Cancer Research, Grand Rapids
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
In reclutamentoStudio osservazionale
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- START Midwest, Grand Rapids
Studi su Cancro metastatico in altre città
- Houston, TX104 studi
- New York City, NY93 studi
- Nashville, TN70 studi
- Boston, MA63 studi
- Los Angeles, CA57 studi
- St. Louis, MO54 studi
- Arlington, VA53 studi
- Philadelphia, PA46 studi
- Chicago, IL45 studi
- San Antonio, TX44 studi
- Washington, DC43 studi
- Dallas, TX42 studi
Altri studi a Grand Rapids
- Cancro del polmone non a piccole cellule44 studi
- Cancro colorettale40 studi
- Cancro (tutti i tipi)28 studi
- Cancro al seno26 studi
- Cancro ovarico24 studi
- Cancro alla prostata19 studi
- Cancro dell'endometrio18 studi
- Cancro dello stomaco18 studi
- Cancro pancreatico18 studi
- Melanoma17 studi
- Carcinoma a cellule squamose della testa e del collo15 studi
- Cancro al seno triplo negativo15 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.